Close Menu
Home › Rosetta Genomics, Meir Medical Partner on microRNA Biomarker Study

Rosetta Genomics, Meir Medical Partner on microRNA Biomarker Study

May 23, 2017

NEW YORK (GenomeWeb) – Rosetta Genomics announced today that it has partnered with Israel's Meir Medical Center to develop a microRNA-based test to identify non-small cell lung cancer (NSCLC) patients who would benefit from a specific class of immunotherapeutics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Featured Webinar

A New Multiplex Syndromic System For Respiratory Diagnosis And Improved Patient Care

Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison (Part 2): Best NGS Approaches for Human Transcriptome Sequencing

Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Featured Webinar

Advancing Agricultural Genomics with Low-Cost NGS Genotyping

Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

What's Popular?

In Molecular Diagnostics

  1. Academic, Community, and Health System Hospitals Face Unique Hurdles Implementing Precision Medicine

    Premium

  2. TGen Inks Tuberculosis Test Deal with Advanced Biological Laboratories

  3. SpeeDx Signs Distributor Deals in Middle East

  4. Biocept to Raise $8.2M in Direct Offering

  5. Constellation Alpha Capital to Acquire DermTech

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.